Evidence map›Paper›PMID 41479619›Full record

ArticleRevista de salud publica (Bogota, Colombia)2025

[DASS-9: Toward a more efficient measure of emotional symptoms].

Carlos Iván Orellana, Ligia María Orellana

Abstract readEnglish Abstract
In one paragraph

Article in Revista de salud publica (Bogota, Colombia), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carlos Iván OrellanaCO: Psicól. Ph. D. Ciencias Sociales. Departamento de Psicología y Salud Pública, Universidad Centroamericana José Simeón Cañas. La Libertad, El Salvador. corellana@uca.edu.sv Universidad Centroamericana José Simeón Cañas Departamento de Psicología y Salud Pública Universidad Centroamericana José Simeón Cañas La Libertad El Salvador corellana@uca.edu.sv.
Ligia María OrellanaLO: Psicól. Ph. D. Psicología. Departamento de Psicología, Universidad de La Frontera. Temuco, Chile. ligia.orellana@ufrontera.cl Universidad de La Frontera Departamento de Psicología Universidad de La Frontera Temuco Chile ligia.orellana@ufrontera.cl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To examine the metric properties and practical benefits of the DASS-9, a shortened version of the well-known DASS-21, a scale for measuring emotional symptoms. Methods: Based on data from previous research with Salvadoran adult population, a 9-item scale was developed to measure emotional symptomatology. Results: The DASS-9 shows the expected triadic factorial structure (depression, anxiety, and stress), high levels of internal consistency (a > 0.86) and evidence of criterion-concurrent validity (i.e., correlations with daily disruption or fear of contagion) that emulate the results of the original research, but with a cutoff of almost 60% of the original items. Conclusions: The DASS-9 shows adequate psychometric properties and is a more efficient alternative for the study of emotional symptoms in Salvadoran population, and in Latin American population as well. The wide use of the DASS-21 in Latin America during the pandemic and the current high incidence of emotional problems globally, make it advisable to create shorter scales that strengthen interest and research on emotional symptomatology.

Indexed as

Affective SymptomsAnxietyDepressionAdolescentAdultAgedFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsStress, PsychologicalYoung Adultanxietydepressionincidencemental health (source: MeSH, NLM)prevalencepsychometricsstress

Identifiers

PMID41479619
PMCPMC12755209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.